Defunct Company
Total Trials
93
As Lead Sponsor
0
As Collaborator
Total Enrollment
42,111
NCT00319592
A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX
Phase: Phase 2
Role: Collaborator
Start: May 31, 2005
Completion: Sep 30, 2006
NCT00435448
Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Phase: Phase 3
Start: Jun 30, 2005
Completion: Dec 31, 2006
NCT00282503
Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Acute Graft Versus-Host Disease
Start: Jan 31, 2006
Completion: Not specified
NCT00637728
Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients
Start: Jun 30, 2006
NCT00637806
Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension
NCT00607386
Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Therapy
Phase: Phase 4
Start: Dec 31, 2007
Completion: Jul 8, 2011
NCT00640016
A Study to Assess the Efficacy, Safety, and Tolerability of CAT-354 in Subjects With Asthma
Start: Jan 31, 2008
Completion: Jul 31, 2008
NCT00672581
Pharmacokinetics, Safety & Tolerability of ZD4054 (Zibotentan) in Subjects With Normal, Mild, Moderate and Severe Hepatic Impairment
Phase: Phase 1
Start: Apr 30, 2008
Completion: Mar 31, 2009
NCT00738595
Phase II Study to Evaluate the Effectiveness of EVT 302 in Smoking Cessation.
Start: Aug 31, 2008
Completion: May 31, 2009
NCT00971334
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Phase: N/A
Start: Aug 31, 2009
Completion: Dec 31, 2011
NCT01063920
Rates of Gastric Ulcer by Endoscopy in Knee Osteoarthritis Patients Receiving LT-NS001 Versus Naprosyn®
Phase: Phase 2/3
Start: Feb 28, 2010
Completion: Nov 30, 2010
NCT01143064
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
Start: Jun 30, 2010
Completion: Mar 31, 2014
NCT01144455
Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma
Completion: Dec 31, 2014
NCT01002079
Drug-Drug Interaction Study With Rifampin
Start: Aug 31, 2010
Completion: Oct 31, 2010
NCT01211808
Effect of Diltiazem on Pharmacokinetics of BMS-914392
Start: Sep 30, 2010
NCT01211821
Effect of BMS-914392 on Pharmacokinetics of Metoprolol
NCT01286649
Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia
Phase: Phase 1/2
Start: Dec 31, 2010
Completion: Feb 23, 2017
NCT01307020
Analgesic Effect of Different Combinations of Dexketoprofen Trometamol With Tramadol Hydrochloride in a Model of Moderate to Severe Pain
Start: Feb 28, 2011
Completion: Oct 31, 2011
NCT01325623
Seizure Detection and Automatic Magnet Mode Performance Study
Start: Mar 31, 2011
Completion: Jul 31, 2015
NCT01330381
Prucalopride in Pediatric Subjects With Functional Constipation
Start: Apr 28, 2011
Completion: Mar 1, 2013
NCT01454089
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Start: Oct 31, 2011
Completion: Nov 30, 2014
NCT02001974
Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Start: Feb 27, 2012
Completion: Jan 15, 2015
NCT01550003
Pediatric Arthritis Study of Certolizumab Pegol
Start: Mar 8, 2012
Completion: Apr 8, 2024
NCT01567956
Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis; Efficacy, Safety and Tolerability Study
Start: Apr 30, 2012
Completion: Jan 31, 2014
NCT01764737
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
Start: Dec 31, 2012
NCT01803867
An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis
Start: Mar 31, 2013
Completion: Jan 31, 2015
NCT01984723
EVP-6124 Renal Impairment Study
Start: Jun 30, 2013
NCT01984736
EVP-6124 Hepatic Impairment Study
NCT02240290
Study to Evaluate the Absorption, Distribution, Break Down and Elimination and the Safety of 14C-Labeled Tozadenant
Start: Sep 30, 2013
Completion: Oct 31, 2013
NCT02088957
Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic Seizures
Start: Mar 31, 2014
Completion: Oct 31, 2014
NCT02227355
Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's Disease
Start: Sep 30, 2014
Completion: Jun 30, 2016
NCT02207530
Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Start: Oct 23, 2014
Completion: Jul 6, 2020
NCT02276053
Study of Lacosamide as an Adjunctive Drug Treatment for Epilepsy in Patients With Brain Tumors
Start: Nov 27, 2014
Completion: Dec 4, 2017
NCT02299661
Pilot PK/PD Study of DS-1093a in Patients With Chronic Kidney Disease
Start: Nov 30, 2014
Completion: May 31, 2015
NCT02432664
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of ODM-108: in Healthy Male Volunteers
Start: Apr 14, 2015
Completion: Apr 22, 2016
NCT02319044
Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck
Start: Apr 15, 2015
NCT02398461
An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse
Start: Apr 30, 2015
Completion: Sep 21, 2017
NCT02430909
Multiple Dose Study of UCB4940 as add-on to Certolizumab Pegol in Subjects With Rheumatoid Arthritis
Completion: Apr 30, 2017
NCT02446912
Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
Start: Jun 9, 2015
Completion: Jul 17, 2018
NCT04110535
Abuse Potential of Intravenous Remimazolam Compared to Midazolam and Placebo in Recreational CNS Depressant Users
Start: Jun 23, 2015
Completion: Oct 6, 2015
NCT02446899
Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
Start: Jul 9, 2015
Completion: Sep 27, 2018
NCT02370238
A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer
Start: Jul 29, 2015
Completion: Mar 23, 2020
NCT02491437
A Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Crinone 8% Intravaginal Progesterone Gel 90 mg Daily for Luteal Support in In-Vitro Fertilization (LOTUS II)
Start: Jul 31, 2015
Completion: May 31, 2017
NCT02495844
A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy
Completion: Jul 31, 2017
NCT02523859
Study of the Efficacy and Safety of Remimazolam in General Anesthesia in Adults Undergoing Cardiac Surgery
Completion: Mar 31, 2016
NCT02424734
Safety, Tolerability and Efficacy of Ceftaroline in Paediatrics With Late-Onset Sepsis
Start: Aug 4, 2015
Completion: Dec 26, 2017
NCT02497781
Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs)
Start: Sep 24, 2015
Completion: Sep 15, 2017
NCT03363477
Study of Pharmacodynamic Equivalence of Enoxaparin Rovi to Clexane®, in Healthy Volunteers
Start: Sep 25, 2015
Completion: Dec 1, 2015
NCT02610543
UCB Proof of Concept Study in Patients With Primary Sjögren's Syndrome
Start: Oct 31, 2015
Completion: Dec 5, 2017
NCT04113564
Absolute Oral Bioavailability of Remimazolam
Start: Nov 3, 2015
Completion: Nov 20, 2015
NCT02602860
A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy Volunteers
Start: Nov 30, 2015
Completion: Sep 30, 2017
NCT02647697
Study to Evaluate Properties of Radiprodil Given in Oral Solution to Healthy Volunteers
Start: Jan 31, 2016
Completion: Feb 29, 2016
NCT02725593
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Start: Jun 22, 2016
Completion: Apr 6, 2020
NCT02794285
Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
Start: Jun 30, 2016
Completion: Dec 21, 2021
NCT02817828
E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - EU/Russia Study
Completion: Apr 26, 2018
NCT02851485
Bioavailability Study With GLPG1972
Start: Jul 31, 2016
Completion: Aug 31, 2016
NCT02817841
E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - United States/Canada Study
Start: Aug 30, 2016
Completion: Nov 16, 2018
NCT03110276
Study Evaluating Safety, Tolerability and Pharmacokinetics of EYP001a in Healthy Male Subjects
Start: Aug 31, 2016
Completion: Mar 31, 2017
NCT02918539
Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
Start: Oct 31, 2016
Completion: Oct 18, 2017
NCT02454712
Study of PF614 Compared to OxyContin® in Healthy Volunteers (PF614-101)
Start: Nov 16, 2016
Completion: Jan 18, 2018
NCT03320616
EYP001a Food Effect Study in Subjects With Chronic Hepatitis B Virus (HBV) Infection
Start: Feb 10, 2017
Completion: Oct 12, 2017
NCT03329014
A Trial of Intranasal Remimazolam Pharmacokinetics, Pharmacodynamics, Safety and Bioavailability
Start: May 15, 2017
Completion: Jun 14, 2017
NCT03475862
Nasal Human Abuse Potential of PTI-821
Completion: Dec 15, 2017
NCT04113343
Oral Remimazolam With and Without Alcohol in Healthy Female Subjects
Start: May 30, 2017
Completion: Aug 9, 2017
NCT03312777
Omnitram Pharmacokinetic and Analgesic Study Following CY2D6 Inhibition With Paroxetine In Healthy Volunteers
Start: Oct 31, 2017
Completion: Dec 22, 2017
NCT03395704
A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis
Start: Nov 29, 2017
Completion: Oct 28, 2019
NCT03505099
Pre-Symptomatic Study of Intravenous Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy (SMA) for Patients With Multiple Copies of SMN2
Start: Apr 2, 2018
Completion: Jun 15, 2021
NCT03444324
Adjusted Fibrinogen Replacement Strategy
Start: Apr 3, 2018
Completion: Nov 21, 2023
NCT03493698
A Fixed-Sequence, Drug-Drug Interaction Study Between Multiple Oral Doses of Inarigivir Soproxil and a Single Oral Dose of Midazolam in Healthy Subjects
Start: May 7, 2018
Completion: Aug 27, 2018
NCT03580707
Does BRV Have Faster Onset Time & Greater Effect Than LEV in Epilepsy Pts Using PPR Pharmacodynamic Efficacy Endpoint
Start: Jun 1, 2018
Completion: Dec 31, 2018
NCT03686683
Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer
Start: Oct 18, 2018
Completion: Mar 10, 2023
NCT03691584
Phase 1, Safety and Bronchopulmonary PK Study in Healthy Volunteers
Start: Nov 26, 2018
Completion: Dec 18, 2019
NCT03854409
A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I Disorder
Start: Jan 31, 2019
Completion: Feb 20, 2020
NCT03880487
A Single and Multiple Ascending Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of KP-1199
Start: Mar 12, 2019
Completion: Apr 21, 2020
NCT03872596
Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder
Start: Mar 27, 2019
Completion: Nov 27, 2019
NCT03837184
Single-Dose Gene Replacement Therapy Using for Patients With Spinal Muscular Atrophy Type 1 With One or Two SMN2 Copies
Start: May 31, 2019
Completion: Jun 29, 2021
NCT04023721
Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor
Start: Jun 18, 2019
Completion: Jul 16, 2020
NCT04018599
Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS
Start: Jul 15, 2019
Completion: Mar 17, 2020
NCT03996694
Single Dose Crossover Study to Compare the Respiratory Drive After Administration of Belbuca, Oxycodone and Placebo.
Start: Jul 23, 2019
Completion: Oct 27, 2019
NCT04039880
Absorption, Metabolism and Excretion of 14C-olorofim in Man
Start: Jul 30, 2019
Completion: Sep 30, 2019
NCT04059198
Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus
Start: Oct 10, 2019
Completion: Apr 2, 2020
NCT04115956
A Clinical Study of Melphalan Flufenamide (Melflufen) and Dexamethasone for Patients With Immunoglobulin Light Chain (AL) Amyloidosis
Start: Aug 6, 2020
Completion: Jan 5, 2022
NCT04520360
Bioavailability and Food Effect Study of 3 Types of Carisbamate
Start: Aug 27, 2020
Completion: Oct 6, 2021
NCT04559126
A Study of EDP-297 in Healthy Subjects
Start: Sep 8, 2020
Completion: Jun 21, 2021
NCT04783753
Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy Subjects
Start: Nov 5, 2020
Completion: Jul 9, 2021
NCT04494061
A Clinical Study to Investigate Interferon Gamma (IFNɣ) Signature in Patients Post HSCT and in Patients With Impaired HSC Proliferation Pre-transplant
Start: Nov 16, 2020
Completion: Aug 31, 2022
NCT04731298
Study to Investigate the Pharmacokinetics, Pharmacodynamics and Assess the Efficacy and Safety to Support Dose Selection of Emapalumab in Pre-empting Graft Failure in Patients at High Risk After HSCT.
Start: May 25, 2021
Completion: Apr 21, 2022
NCT04974723
Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women
Start: Jul 1, 2021
Completion: Sep 30, 2021
NCT04857840
Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH)
Start: Aug 5, 2021
Completion: Jan 9, 2023
NCT05043766
Evaluation of Oral PF614 Relative to OxyContin (PF614-102)
Start: Sep 8, 2021
Completion: Mar 21, 2022
NCT05205863
Dose-Response in PD and Safety of Cofact Under VKA Anticoagulation
Start: Nov 12, 2021
Completion: Sep 3, 2022
NCT05124483
Anti-COVID19 VaccinaTion AKS-452 BOOSTER (ACT-BOOSTER Study)
Start: Apr 21, 2022
Completion: Feb 1, 2023
NCT04457076
Evaluation of the Efficacy, Safety, and Tolerability of LevoCept
Start: Jun 1, 2026
Completion: Jun 1, 2032